Article
SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value.
Blood - 12 Jan 2012
Patnaik Mrinal M, Lasho Terra L, Hodnefield Janice M, Knudson Ryan A, Ketterling Rhett P, Garcia-Manero Guillermo, Steensma David P, Pardanani Animesh, Hanson Curtis A, Tefferi Ayalew
Abstract excerpt
SF3B1 mutations were recently reported in myelodysplastic syndromes (MDSs), especially in the presence of ring sideroblasts (RSs). We sought to define the interaction between SF3B1 mutations, morphology, karyotype, and prognosis in MDS with more than or equal to 15% RS (MDS-RS). We studied 107 patients with MDS-RS, including 48 with refractory anemia with RS (RARS), 43 with refractory cytopenia with multilineage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
